A Pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (50)
Cancer immunoediting: from immunosurveillance to tumor escape
2002 • 4,911 citations
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 • 2,788 citations
Regulatory T cells, tumour immunity and immunotherapy
2006 • 2,009 citations
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
2005 • 1,613 citations
Progress in human tumour immunology and immunotherapy
2001 • 1,327 citations
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006 • 1,263 citations
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
2000 • 679 citations
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
2004 • 525 citations
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
2004 • 368 citations
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
2007 • 337 citations
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
2006 • 333 citations
Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance
2004 • 319 citations
Regulatory T cells in immune surveillance and treatment of cancer
2006 • 257 citations
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation
2003 • 219 citations
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells
2003 • 219 citations
A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity
2001 • 212 citations
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
2006 • 163 citations
Minor histocompatibility antigens in human stem cell transplantation
2003 • 137 citations
Graft-Versus-Tumor Induction With Donor Leukocyte Infusions as Primary Therapy for Patients With Malignancies
1999 • 131 citations
Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells
2003 • 110 citations
Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-γ
2003 • 83 citations
Anti‐tumour response despite loss of donor chimaerism in patients treated with non‐myeloablative conditioning and allogeneic stem cell transplantation
2005 • 82 citations
The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation
2003 • 79 citations
Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response
2006 • 73 citations
Innate Immune Recognition and Suppression of Tumors
2006 • 70 citations
Minor Histocompatibility Antigens
2004 • 70 citations
New Developments in Allotransplant Immunology
2003 • 67 citations
Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation
2006 • 66 citations
Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen
2004 • 62 citations
Current status of haploidentical stem cell transplantation
2006 • 57 citations
Tumour immunology, vaccination and escape strategies
2003 • 54 citations
Vaccination for Leukemia
2006 • 52 citations
Haploidentical Stem Cell Transplantation: The Always Present but Overlooked Donor
2005 • 52 citations
Donor Lymphocyte Infusion: The Use of Alloreactive and Tumor-Reactive Lymphocytes for Immunotherapy of Malignant and Nonmalignant Diseases in Conjunction with Allogeneic Stem Cell Transplantation
2002 • 52 citations
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy
2002 • 49 citations
High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide–driven graft-versus-leukemia effects
2007 • 41 citations
Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity
2007 • 41 citations
Part II: Vaccines for haematological malignant disorders
2004 • 36 citations
Adoptive T cell therapy of solid cancers
2005 • 33 citations
Tumor microenvironments, the immune system and cancer survival.
2005 • 28 citations
Antineoplastic Effects of Partially HLA-Matched Irradiated Blood Mononuclear Cells in Patients With Renal Cell Carcinoma
2003 • 27 citations
Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia
2004 • 26 citations
Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastase
2003 • 25 citations
Expansion of CD8+ Cytotoxic T Cells in vitro and in vivo Using MHC Class I Tetramers
2007 • 21 citations
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes
2002 • 17 citations
Nonmyeloablative Blood Stem Cell Transplantation as Adoptive Allogeneic Immunotherapy for Metastatic Renal Cell Carcinoma
2001 • 16 citations
Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation
2003 • 15 citations
Low Dose Total Body Irradiation Followed by Allogeneic Lymphocyte Infusion for Refractory Hematologic Malignancy—an Updated Review
2004 • 14 citations
Cellular immune therapy for refractory cancers: novel therapeutic strategies
2005 • 12 citations
The basis of T-cell-mediated immunity to chronic myelogenous leukemia
2002 • 11 citations